Blog

A recent study has identified that transmission of hepatitis is possible even when using sterile needles and syringes. MLMIC encourages all medical professionals to remain vigilant with use of proper technique for the administration of injectable medications.

The American Dental Association (ADA) has responded to recent media coverage of a study that had raised concerns about the safety of dental floss. Pointing out that the U.S. Food and Drug Administration has placed no restrictions on the use of dental floss, ADA says it finds “no cause for concern based on current evidence.”

MLMIC asks any objectors or Eligible Policyholders currently involved in an unresolved dispute over cash consideration to read the recent Order from the Superintendent of the New York State Department of Financial Services and review your obligations, available options and the future status of the cash consideration held in escrow.

The latest edition of MLMIC’s The Albany Report focuses policyholder attention on Governor Cuomo’s proposed executive budget and its impact on the medical professional liability insurance market.

A cornerstone of the quality of care provided at any healthcare organization is a culture that provides for the safety of patients and promotes an environment where staff and providers feel comfortable in raising issues or concerns.

MLMIC Insurance Company has received an A+ (Superior) Financial Strength Rating and a Long-Term Issuer Credit Rating of “aa-” from AM Best.

ONC has released a draft strategy it believes will lessen the regulatory and administrative burden of health information technologies, such as EHRs. MLMIC encourages all insured stakeholders to take this opportunity to offer their input.

MLMIC’s Q3 financials show continued strength and stability for New York’s leading medical liability insurer. In a consistently challenging insurance marketplace, it is reassuring to know that MLMIC is sound and ready to serve its policyholders.

The Fall 2018 edition of Dental Dateline – the newsletter for MLMIC-insured dentists – includes a case study about the dangerous combination of poor results and inadequate documentation and a risk management tip on managing patient noncompliance.

Berkshire Hathaway CEO Warren Buffett and MLMIC Chairman of the Board James Reed, M.D., discuss the future of healthcare and MLMIC’s role protecting New York physicians.